Medical Ethics Advisor
RSSArticles
-
Very Few Patients Address ICDs in Advance Care Planning
Some clinicians and patients view deactivation of implantable cardiac devices as morally different from the withdrawal of other life-sustaining interventions, yet very few people address this in advance care planning.
-
Are Hospital Billing Practices Unethical? Chargemaster Still Used To Boost Revenue
U.S. hospitals still are using chargemaster markups to maximize revenues, found a recent study.
-
New Report on Research Integrity: Institutions Also Play a Role
Institutions and environments — not only individual researchers — play an important role in supporting scientific integrity, stresses a new report from the National Academies of Sciences, Engineering, and Medicine.
-
Study: Research on Dying ICU Patients Is Ethically Feasible
Research on critically ill, dying ICU patients is ethically feasible, found a recent study which achieved a 95% consent rate for approached families.
-
Study Sheds Light on Surrogates’ Decision-making
It comes as no surprise to anyone with experience caring for patients at the end of life that family members often have difficulty predicting a patient’s desire for life-sustaining treatments. Reasons for this are less well-understood, however.
-
It’s Not Just MDs: Patient Advocacy Organizations Have Industry Ties, Too
Recent studies have revealed surprising financial ties of patient advocacy organizations: the vast majority receive financial support from drug, device, and biotechnology companies.
-
Research Misconduct Rarely Reported by Authors of Systematic Reviews
Research misconduct — not publishing completed research, duplicate publications, or selective reporting of outcomes — sometimes is identified by authors of systematic reviews, but is rarely reported, found a recent study.
-
NIH Policy on Review of Multicenter Studies: ‘One Size Fits All’
A new National Institutes of Health policy mandates that all domestic sites participating in multicenter research studies use a single institutional review board.
-
Updated Common Rule: ‘Massive Improvement’ For Human Subjects Research
The long-awaited updated Common Rule for federal regulations for ethical conduct of human subjects research is quite different from what was initially proposed.
-
Study: Scientifically Unproven Marketing Claims Very Common on Websites
Marketing claims on websites of complementary and alternative medicine therapies practitioners regarding allergy and asthma often included interventions that were not scientifically supported, according to a new study.